SCHEMBL5656897

SCHEMBL5656897

OCc1cnc2n1CCCC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 2/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
AR P10275 1/20 0.39
RAB9A P51151 1/20 0.39
SLC27A1 Q6PCB7 1/20 0.37
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
POLB P06746 1/20 0.35
PI4KA P42356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25320550 0.94 AR (0.44) HPGDSMN1; SMN2LMNAHTTMAPT
Hydrochloric Acid SCHEMBL5656823 0.84 SMN1; SMN2 (0.46) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL10235027 0.81 MAPK1 (0.47) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL10235437 0.80 MAPK1 (0.50) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL28803885 0.80 HPGD (0.43) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL8233211 0.79 HPGD (0.42) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL2266264 0.78 RXFP1 (0.41) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL7448909 0.78 LMNA (0.46) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL7960846 0.76 LMNA (0.43) HPGDSMN1; SMN2LMNAHTTMAPT
SCHEMBL10234138 0.76 MAPT (0.48) HPGDSMN1; SMN2LMNAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262185-B2 Benzazepine derivative, process for producing the same, and use TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2007-08-28 US disclosed
US-20040235822-A1 Benzazepine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-11-25 US disclosed
EP-1422228-A1 BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Chemical Industries, Ltd. (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235822-A1 Benzazepine derivative, process for producing the same, and use CYP1B1, CYP1A1, CYP2E1 HPGD 2817/4885SMN1; SMN2 1174/4885LMNA 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.